The challenges of recruiting never-smokers with chronic obstructive pulmonary disease from the large population-based Swedish CArdiopulmonary bioImage study (SCAPIS) cohort.

COPD COPD diagnosis SCAPIS never-smokers population-based recruitment spirometry

Journal

European clinical respiratory journal
ISSN: 2001-8525
Titre abrégé: Eur Clin Respir J
Pays: United States
ID NLM: 101662134

Informations de publication

Date de publication:
2024
Historique:
medline: 17 7 2024
pubmed: 17 7 2024
entrez: 17 7 2024
Statut: epublish

Résumé

A substantial proportion of individuals with COPD have never smoked, and it is implied to be more common than previously anticipated but poorly studied. To describe the process of recruitment of never-smokers with COPD from a population-based cohort ( We recruited never-smokers with COPD, aged 50-75 years, from six University Hospitals, based on: 1) post broncho-dilator forced expiratory volume in 1 second/forced vital capacity (FEV Data on respiratory symptoms, health status, and medical history were collected from 492 individuals, since 32 were excluded at a second data review (declined or previous smoking), prior to the first visit. Due to not matching the required lung function criteria at a second spirometry, an additional 334 (68%) were excluded. These exclusions were by reason of: FEV The challenges of a recruitment process of never-smokers with COPD were shown, including the importance of correct spirometry testing and strict inclusion criteria. Our findings highlight the importance of repeated spirometry assessments for improved accuracy in diagnosing COPD.

Sections du résumé

Background UNASSIGNED
A substantial proportion of individuals with COPD have never smoked, and it is implied to be more common than previously anticipated but poorly studied.
Aim UNASSIGNED
To describe the process of recruitment of never-smokers with COPD from a population-based cohort (
Methods UNASSIGNED
We recruited never-smokers with COPD, aged 50-75 years, from six University Hospitals, based on: 1) post broncho-dilator forced expiratory volume in 1 second/forced vital capacity (FEV
Results UNASSIGNED
Data on respiratory symptoms, health status, and medical history were collected from 492 individuals, since 32 were excluded at a second data review (declined or previous smoking), prior to the first visit. Due to not matching the required lung function criteria at a second spirometry, an additional 334 (68%) were excluded. These exclusions were by reason of: FEV
Conclusions UNASSIGNED
The challenges of a recruitment process of never-smokers with COPD were shown, including the importance of correct spirometry testing and strict inclusion criteria. Our findings highlight the importance of repeated spirometry assessments for improved accuracy in diagnosing COPD.

Identifiants

pubmed: 39015382
doi: 10.1080/20018525.2024.2372903
pii: 2372903
pmc: PMC11251440
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2372903

Informations de copyright

© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Déclaration de conflit d'intérêts

No potential conflict of interest was reported by the author(s).

Auteurs

Pernilla Sönnerfors (P)

Respiratory Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Medical Unit Occupational Therapy and Physiotherapy, Women´s Health and Allied Health Professionals Theme, Karolinska University Hospital, Stockholm, Sweden.

Petra Kristina Jacobson (PK)

Department of Respiratory Medicine in Linköping, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Anders Andersson (A)

COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden.
COPD Center Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Annelie Behndig (A)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Leif Bjermer (L)

Department of Clinical Sciences, Respiratory medicine, Allergology and Palliative Medicine, Lund University, Lund, Sweden.

Anders Blomberg (A)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Heléne Blomqvist (H)

Respiratory Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.

Jonas Erjefält (J)

Unit of Airway inflammation, Department of Experimental Medicine Sciences, Lund University, Lund, Sweden.

Maria Friberg (M)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Kristina Lamberg Lundström (K)

Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.

Anna Lundborg (A)

COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Andrei Malinovschi (A)

Department of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden.

Hans Lennart Persson (HL)

Department of Respiratory Medicine in Linköping, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Ellen Tufvesson (E)

Department of Clinical Sciences, Respiratory medicine, Allergology and Palliative Medicine, Lund University, Lund, Sweden.

Åsa Wheelock (Å)

Respiratory Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.

Christer Janson (C)

Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.

Carl Magnus Sköld (CM)

Respiratory Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.

Classifications MeSH